Advances in the Treatment of Renal Cell Carcinoma

Advances in the Treatment of Renal Cell Carcinoma

This Special Issue of Cancers focuses on new advances in the treatment of renal cell carcinoma, both surgical and pharmacological (and combinations of these), and novel approaches to tackle treatment resistance and improve our understanding of this phenomenon.

Saved in:
Bibliographic Details
Other Authors: Reynolds, Paul (Editor), Stewart, Grant D (Editor)
Format: Book Chapter
Published: Basel MDPI - Multidisciplinary Digital Publishing Institute 2022
Subjects:
Medicine
renal cell carcinoma
autophagy
hydroxychloroquine
chloroquine
ROC-325
cysteine cathepsins
cysteine cathepsin inhibitors
lysosome
renal cancer
metastatic renal cell carcinoma
immune-based combination therapies
network meta-analysis
PD-L1
predictive
biomarker
treatment
TKIs
mRCC
biomarkers
soluble factors
immunotherapy
renal cell carcinoma (RCC)
sunitib resistance
artesunate (ART)
Traditional Chinese Medicine (TCM)
growth inhibition
ferroptosis
reactive oxygen species (ROS)
clear cell renal cell carcinoma
ccRCC
RCC
kidney cancer
evolution
evolutionary trajectory
metastatic
second line therapy
renal cell cancer
immune checkpoint inhibitors
tyrosine kinase inhibitors
individualization
genomic signature
transcriptomic analysis
Online Access:Get Fullteks
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Get Fullteks
DOAB: description of the publication

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items